Moderna (MRNA) Reiterated Hold at Jefferies After AICP Fails to Issue Blanket 3rd Dose Recommendation
Tweet Send to a Friend
Jefferies analyst Michael Yee reiterated a Hold rating and $425.00 price target on Moderna (NASDAQ: MRNA) conservatively noting that despite ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
